Fermer le menu


Innovative startup in Biotechnology, LPS-BioSciences is specialized in bacterial endotoxins. Our goal is to make endotoxins accessible to pharmaceutical industry for vaccine development as antigen or as adjuvant component.The company runs two activities, on one hand a CRO activity for industrial companies, on the other hand a research activity for the development of innovative vaccines adjuvants. The company has developed Boost-LPS, an adjuvant platform that aims at providing innovative adjuvants and antigens to improve vaccines efficiency.


Strategic application domain: Human Medicine

Application market: Infectious Diseases, Oncology

Type of activity: CRO - Tools - R&D platform, Therapeutics, Pharma or Biotech

Technologies: Vaccine, Others

Created on nov. 25th, 2011 - 8 employees



63 rue André Bollier 69307 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.